Pharmacotherapy rounds are designed for pharmacy residents and fellows, residency and fellowship preceptors, faculty, and practicing pharmacists. Activities are offered free of charge to all participants.
Pharmacotherapy Rounds at the University of Maryland School of Pharmacy are held in room N211, unless otherwise noted.
Also available is a printer-friendly 2022-2023 PT Rounds Schedule, including topic and application deadlines.
Tuesday, September 13, 12:30-1:30 p.m.
Bring the Beat In: The Increasing Role of Rhythm Control in Atrial Fibrillation - Ami Patel, PharmD
Small But Mighty: Targeting Lp(a) for Atherosclerotic Cardiovascular Disease Risk Reduction - Aaron Adkisson, PharmD
Tuesday, September 20, 12:30-1:30 p.m.
Two Kinds of Happiness: Antidepressants for Motor Recovery Post-Stroke - Ibtihal Makki, PharmD
PANDEM at the Disco: I Write Sedation Plans Not Benzodiazepines - Reid LaPlante, PharmD
Tuesday, September 27, 12:30-1:30 p.m.
Updates to Fluid Resuscitation in Septic Shock - Sara Hall, PharmD
CAR-T as Salvage Therapy for Diffuse Large B-Cell Lymphoma: Putting the CART Before the Horse? - Katelyn Reiter-Schreurs, PharmD
Tuesday, October 4, 12:30-1:30 p.m.
We’re Bringing Sexy Back: Psychotropic-Induced Sexual Dysfunction Management - Tiffany Khieu, PharmD
Crisis AVERTed: Vasopressin Utility in Hemorrhagic Shock - Grace Erdman, PharmD
Tuesday, October 11, 12:30-1:30 p.m.
Check Yourself Before You Reject Your Graft: Checkpoint Inhibitors in Solid Organ Transplant Recipients - Kenneth Saunders, PharmD
Flozins for FSGS too: Benefits of SGLT2 Inhibitors in patients with FSGS - Kaitlyn Legg, PharmD
Tuesday, October 18, 12:30-1:30 p.m.
A Pharmacist’s Guide to Gender-affirming Medicine - Victoria Fusco, PharmD
How Old is too Old? Overview of Primary Prevention of ASCVD in Older Adults - Christian Macaspac, PharmD
Tuesday, October 25, 12:30-1:30 p.m.
Too much of a good thing: examining cefepime-induced neurotoxicity - Angela Lam, PharmD
Loperamide Abuse and Misuse Trends After Introduction of Safety Measures - Masha Yemets, PharmD
Tuesday, November 8, 12:30-1:30 p.m.
Billing for Pharmacy Services & Value-Based Care - Sarah Chong, PharmD
To Switch or Not To Switch: The Generic Levothyroxine Conundrum - Connie Liang, PharmD
Tuesday, November 15, 12:30-1:30 p.m.
Too Hot to Handle: Impacts of the Climate Crisis on Infectious Diseases - Daniel Mesa, PharmD
Brought to You by the Letter "M": Utilizing the Geriatric 5Ms Model to Optimize Care for Older Adults - Katie Jones, PharmD
Tuesday, November 29, 12:30-1:30 p.m.
"B" Up To Date with Hepatitis B - Taylor Southers, PharmD
Tuesday, December 13, 12:30-1:30 p.m.
Management of Volume Overload in ADHF - Breah Johnson, PharmD
Tuesday, December 20, 12:30-1:30 p.m.
No More Monkeying Around: An Overview of Monkeypox Management - Tori Segeleon, PharmD
Wednesday, January 11, 12:30-1:30 p.m.
Starting Small: Buprenorphine Microinduction - Celina Ferey, PharmD
Wednesday, January 18, 12:30-1:30 p.m.
Sorry, the old guidelines can't come to the phone right now: A new era of treatment of NAFLD - Alyssa Castillo, PharmD
Wednesday, January 25, 12:30-1:30 p.m.
Therapeutic Drug Monitoring for Antibiotics – Ready for prime time? - Adriana Gardner, PharmD
Wednesday, February 1, 12:30-1:30 p.m.
Pick a Number 1 or 2. Standard of Care Versus Combination Therapy in MRSA Bacteremia - Princess Asadu Bempah, PharmD
Terlipressin in Hepatorenal Syndrome - Benjamin Miller, PharmD
Wednesday, February 8, 12:30-1:30 p.m.
Management of bleeding complications in antiphospholipid syndrome - Sapna Basappa, PharmD
Wednesday, February 15, 12:30-1:00 p.m.
2022 AHA/ACC/HFSA Guideline Updates for the Management of Heart Failure - Daniel Abate, PharmD
Wednesday, February 22, 12:30-1:30 p.m.
Elfapegrastim for Chemotherapy Induced Neutropenia: Is Neu-er Better? - Aisha Siddique, PharmD
Is Andexanet truly the ALPHA over 4-F PCC for the reversal of factor Xa inhibitors in life-threatening hemorrhage? - Lauren Proctor, PharmD
Wednesday, March 8, 12:30-1:30 p.m.
What's New This Season on RSV - Lorraine Chang, PharmD
The Basics of AB(COPD)E: Updates from the 2023 GOLD Report - Ji-Yeon Kim, PharmD
Wednesday, March 15, 12:30-1:30 p.m.
Define the Duration: DAPT for DES - Nasim Mavahebitabatabaei, PharmD
Wednesday, March 22, 12:30-1:30 p.m.
From SAMSON to siRNA: Approaches to the Patient with Statin-Associated Muscle Symptoms - Alex Martschenko, PharmD
Wednesday, March 29, 12:30-1:30 p.m.
Let's ThiNK About It: Tenecteplase in Acute Ischemic Stroke - Lina Park, PharmD
Wednesday, April 5, 12:30-1:30 p.m.
Management of Volume Overload in ADHF - Breah Johnson, PharmD
Wednesday, April 12, 12:30-1:30 p.m.
LDL Cholesterol: How Low Can You Go? - Victoria Iervasi, PharmD
The ABCs on ALS: Introducing AMX0035 - Danielle Yu, PharmD
Wednesday, April 19, 12:30-1:30 p.m.
Administration of Oral Medications in Patients with Enteral Feeding Tubes - Catherine Kim, PharmD
Racial Disparities In Pain Management - Zaria Comer, PharmD
Wednesday, April 26, 12:30-1:30 p.m.
Economic burden of patents and regulatory exclusivities on ICS/LABA inhalers in end-stage COPD patients - Farideh Sistani, PharmD
Wednesday, May 3, 12:30-1:30 p.m.
End-of-Life Care in Heart Failure with Reduced Ejection Fraction - Derek Edwards, PharmD
|The University of Maryland School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity meets the ACPE criteria for one contact hour (0.1 CEU) of continuing education credit. Statements of credit will be posted to CPE Monitor within 60 days of the activity date for participants who successfully complete the activity. Successful completion of this activity requires your signature on the sign-in sheet (or if participating virtually, your name and email address entered into the Blackboard Collaborative chat), the completion of an online activity evaluation form, and participation in the entire activity. The online activity evaluation must be completed within three days following the conclusion of the activity. This activity is fully provided by the University of Maryland School of Pharmacy.|
|The Johns Hopkins Hospital Department of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|